CNN-PepPred

CNN-PepPred identifies binding patterns in peptide sets using convolutional neural networks to predict peptide binding to HLA class II molecules for applications in vaccine development and immunotherapy.

Key Features:

• Pattern discovery: Uncovers complex binding motifs and patterns within peptide sequences relevant to peptide–MHC interactions.
• Peptide–HLA class II binding prediction: Predicts peptide binding affinities and binding likelihoods for HLA class II molecules.
• Convolutional neural network (CNN) architecture: Employs CNNs as the core deep learning algorithm for sequence pattern recognition.
• Model training and evaluation: Supports training, evaluation, application, and visualization of predictive models.
• Python-based implementation: Implemented in Python for computational workflows.
• Data resources: Uses peptide datasets sourced from the Immune Epitope Database (IEDB).
• Computation environments: Operates on CPU and GPU processing environments and across multiple operating systems.

Scientific Applications:

• Vaccine development: Identifies peptide candidates and binding patterns to inform vaccine antigen selection and epitope design.
• Immunotherapy: Supports discovery of peptide–MHC interactions relevant to personalized immunotherapies and tumor antigen identification.

Methodology:

Uses convolutional neural networks to analyze peptide sequences, train and evaluate predictive models, and predict binding affinities to HLA class II molecules using peptide datasets (e.g., IEDB).